Iranian Journal of Pharmaceutical Research

1. Efficacy of Adding Bortezomib to Salvage Chemotherapy in Relapsed/refractory Acute Myeloid Leukemia a Prospective Non-Interventional Study

Volume 20, Issue 4, Autumn 2021, Pages 29-32

Mojtaba Ghadiany; Mahdi Tabarraee; Behnaz Varaminian; Sina Salari

View Article
PDF 379.47 K

2. Evaluation of ATG7 and Light Chain 3 (LC3) Autophagy Genes Expression in Newly Diagnosed AML Patients

Volume 18, Issue 2, Spring 2019, Pages 1060-1066

Mohamadreza Mohamadimaram; Mehdi Allahbakhshian Farsani; Amin Mirzaeian; Shaghayegh Shahsavan; Abbas Hajifathali; Sayeh Parkhideh; Mohammadhossein Mohammadi

View Article
PDF 516.44 K

3. CDKN2B methylation correlates with survival in AML patients

Volume 16, Issue 4, Autumn 2017, Pages 1600-1611

Esmat Kamali Dolatabadi; Mohammadreza Ostadali Dehaghi; Naser Amirizadeh; Kazem Parivar; Reza Mahdian

View Article
PDF 643.83 K

1. Efficacy of Adding Bortezomib to Salvage Chemotherapy in Relapsed/refractory Acute Myeloid Leukemia a Prospective Non-Interventional Study

2. Evaluation of ATG7 and Light Chain 3 (LC3) Autophagy Genes Expression in Newly Diagnosed AML Patients

3. CDKN2B methylation correlates with survival in AML patients

Journal Archive